VNX001

· Vaneltix Pharma, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for VNX001, covering 2026-01-22 to 2026-01-22. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of VNX001 Compared to Its Individual Components (Lidocaine and Heparin) or Placebo in Subjects With IC/BPS [Phase 2]

See pricing